Alpha Laboratories has expanded the offering of Calprotectin tests with the launch of the BÜHLMANN IBDoc® which is the first CE marked Calprotectin home test. Utilising sophisticated technology contained within smartphones, the IBDoc enables patients to perform quantitative calprotectin tests at home.
Under the guidance of clinicians, regular monitoring is now possible for IBD patients in the comfort of their own home. This approach allows for a customised, patient centric approach for therapy and disease management helping to predict possible relapse and assisting with therapy optimisation.
The IBDoc Portal is a secure, encrypted, user friendly application for clinical professionals to manage their IBD patients. Each patient test profile can be tailored by the clinician:
The categories are defaulted to:
|100 – 300 ug/g||Amber|
The levels are customisable by the clinician for each individual patient.